I sense that there is a lot of confidence in the OSA project - I mean they are setting up an office in the U.S after all. Remembering the OSA milestone has also gotten a lot closer since the start of the Nasdaq journey. They do look set to attract bigger fish. I think the scale of the project lends itself to potential defensive and aggressive commercial interest from pharma/strategic market players. IHL will be in the box seat IMO.